Dean Schorno
Finanzdirektor/CFO bei RIGEL PHARMACEUTICALS, INC.
Vermögen: 443 180 $ am 30.04.2024
Aktive Positionen von Dean Schorno
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| RIGEL PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 29.05.2018 | - |
Karriereverlauf von Dean Schorno
Ehemalige bekannte Positionen von Dean Schorno
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
23andMe, Inc.
 23andMe, Inc. Medical SpecialtiesHealth Technology 23andMe, Inc. provides genetic information using DNA analysis technologies and web-based interactive tools. It enables individuals to gain deeper insights into personal ancestry, genealogy, and inherited traits. The company was founded by Linda Avey, Paul L. Cusenza and Anne E. Wojcicki in 2006 and is headquartered in Sunnyvale, CA. | Geschäftsführer | 17.08.2015 | 01.05.2018 |
| Finanzdirektor/CFO | 17.08.2015 | 01.05.2018 | |
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | Finanzdirektor/CFO | 24.06.2014 | 10.08.2015 |
| GENOMIC HEALTH, INC. | Finanzdirektor/CFO | 10.01.2011 | 01.07.2014 |
| Investor Relations Kontakt | 01.07.2003 | 01.07.2014 | |
| Public Communications Contact | 01.07.2003 | 01.07.2014 | |
| Corporate Officer/Principal | 01.02.2010 | 10.01.2011 |
Ausbildung von Dean Schorno
| University of California, Berkeley | Undergraduate Degree |
| Golden Gate University | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
Operativ
| Director of Finance/CFO | 4 |
| Investor Relations Contact | 1 |
| Public Communications Contact | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | Health Technology |
| RIGEL PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Genomic Health, Inc.
 Genomic Health, Inc. Medical SpecialtiesHealth Technology Genomic Health, Inc. engages in the provision of genomic-based diagnostic tests. Its tests analyze the underlying biology of cancers, allowing physicians and patients to make individualized treatment decisions. The firm uses a platform which translates a massive amount of clinical and genomic data into clinically actionable results for treatment planning. The company was founded by Patrick F. Terry, Joffre B. Baker, Randal W. Scott, and Steven Shak in August 2000 and is headquartered in Redwood City, CA. | Health Technology |
23andMe, Inc.
23andMe, Inc. Medical SpecialtiesHealth Technology 23andMe, Inc. provides genetic information using DNA analysis technologies and web-based interactive tools. It enables individuals to gain deeper insights into personal ancestry, genealogy, and inherited traits. The company was founded by Linda Avey, Paul L. Cusenza and Anne E. Wojcicki in 2006 and is headquartered in Sunnyvale, CA. | Health Technology |
- Börse
- Insiders
- Dean Schorno
- Erfahrung
